Evidence map›Paper›PMID 28106166›Full record

ArticleNature communications2017

Rapid generation of hypomorphic mutations.

Laura L Arthur, Joyce J Chung, Preetam Jankirama, Kathryn M Keefer, Igor Kolotilin, Slavica Pavlovic-Djuranovic, Douglas L Chalker, Vojislava Grbic, Rachel Green, Rima Menassa and 3 more

Erratum issuedAbstract readEvaluation Study
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Gene dosage effects of poly(A) track-engineered hypomorphs.Molecular therapy. Nucleic acids · 2021
    Article
  4. eLife · 2020
    Article
  5. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Review
  6. Article
  7. Article
  8. Review
  9. PolyA tracks, polybasic peptides, poly-translational hurdles.Wiley interdisciplinary reviews. RNA · 2018
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Laura L ArthurDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Joyce J ChungDepartment of Biology, Washington University, St Louis, Missouri 63105, USA.
Preetam JankiramaDepartment of Biology, The University of Western Ontario, 1151 Richmond Street, London, Ontario, Canada N6A5B7.
Kathryn M KeeferDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Igor KolotilinScattered Gold Biotechnology Inc. 14 Denali Terrace, London, Ontario, Canada N5X 3W2.
Slavica Pavlovic-DjuranovicDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Douglas L ChalkerDepartment of Biology, Washington University, St Louis, Missouri 63105, USA.
Vojislava GrbicDepartment of Biology, The University of Western Ontario, 1151 Richmond Street, London, Ontario, Canada N6A5B7.
Rachel GreenDepartment of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, USA.
Rima MenassaScience and Technology Branch, Agriculture and Agri-Food Canada, 1391 Sandford Street, London, Ontario, Canada N5V4T3.
Heather L TrueDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
James B SkeathDepartment of Genetics, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Sergej DjuranovicDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.ORCID 0000-0002-9417-0822

Funding

TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
THE ROLE OF ADAMTS-A IN REGULATING CNS STRUCTURE AND RESTRICTING CELL MIGRATIONR01NS036570 · NINDS · WASHINGTON UNIVERSITY · PI SKEATH, JAMES BENJAMIN · 1997 to 2021
$6.4M
A PRION REVEALS COMPLEX TRAITS AND PHENOTYPIC DIVERSITYR01GM072778 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 2005 to 2014
$3.1M
MECHANISMS FOR MODULATION OF MIRNA-MEDIATED GENE SILENCINGR01GM112824 · NIGMS · WASHINGTON UNIVERSITY · PI DJURANOVIC, SERGEJ · 2015 to 2023
$3.1M
NIGMS NIH HHS R01 GM072778NIGMS NIH HHS R01 GM112824NIGMS NIH HHS T32 GM007067NINDS NIH HHS R01 NS036570
6 · The paper itself

Abstract

Hypomorphic mutations are a valuable tool for both genetic analysis of gene function and for synthetic biology applications. However, current methods to generate hypomorphic mutations are limited to a specific organism, change gene expression unpredictably, or depend on changes in spatial-temporal expression of the targeted gene. Here we present a simple and predictable method to generate hypomorphic mutations in model organisms by targeting translation elongation. Adding consecutive adenosine nucleotides, so-called polyA tracks, to the gene coding sequence of interest will decrease translation elongation efficiency, and in all tested cell cultures and model organisms, this decreases mRNA stability and protein expression. We show that protein expression is adjustable independent of promoter strength and can be further modulated by changing sequence features of the polyA tracks. These characteristics make this method highly predictable and tractable for generation of programmable allelic series with a range of expression levels.

Indexed as

Genetic TechniquesMutationPoly APromoter Regions, GeneticProtein BiosynthesisProteinsRNA StabilityPoly AProteins

Identifiers

PMID28106166
PMCPMC5263891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.